Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | HTR1A | P08908 | 1/20 | 0.33 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | DRD1 | P21728 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.33 |
| ▸ | DRD3 | P35462 | 1/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18122238 | 1.00 | CHRM2 (0.33) | CHRM2HTR1AADRA2ACHRM1DRD1 | |
| SCHEMBL18122305 | 0.99 | POLB (0.32) | CHRM2HTR1AADRA2ACHRM1DRD1 | |
| SCHEMBL19901170 | 0.91 | CHRM2 (0.30) | CHRM2HTR1AADRA2ACHRM1DRD1 | |
| SCHEMBL18594521 | 0.89 | IDO1 (0.31) | — | |
| SCHEMBL15497874 | 0.88 | POLB (0.33) | CHRM2HTR1AADRA2ACHRM1DRD1 | |
| SCHEMBL18760055 | 0.86 | PDK2 (0.31) | — | |
| SCHEMBL17697954 | 0.86 | ACHE (0.32) | CHRM2HTR1AADRA2ACHRM1DRD1 | |
| SCHEMBL19451455 | 0.84 | RARA (0.32) | — | |
| SCHEMBL19901169 | 0.84 | PPARG (0.31) | — | |
| SCHEMBL18594529 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240026041-A1 | Polyethylene and Preparation Method Thereof | LG CHEM, LTD. (KR) | 2024-01-25 | — | — | US | disclosed |
| US-20240018283-A1 | ORGANIC-INORGANIC HYBRID POLYOLEFIN COMPOSITE AND PREPARATION METHOD THEREOF | LG CHEM, LTD. (KR) | 2024-01-18 | — | — | US | disclosed |
| US-11702488-B2 | Polyethylene and chlorinated polyethylene thereof | LG CHEM, LTD. | 2023-07-18 | — | — | US | disclosed |
| US-9963527-B2 | Transition metal compound, catalyst composition comprising the same, and method of preparing polyolefin | LG CHEM, LTD. (KR) | 2018-05-08 | — | — | US | disclosed |
| US-9963527-B2 | Transition metal compound, catalyst composition comprising the same, and method of preparing polyolefin | LG CHEM, LTD. (KR) | 2018-05-08 | — | — | US | disclosed |
| US-9926395-B2 | Hybrid supported metallocene catalyst | LG CHEM, LTD. (KR) | 2018-03-27 | — | — | US | disclosed |
| US-9902789-B2 | Method for preparing hybrid supported metallocene catalyst | LG CHEM, LTD. (KR) | 2018-02-27 | — | — | US | disclosed |
| US-20170198074-A1 | TRANSITION METAL COMPOUND, CATALYST COMPOSITION COMPRISING THE SAME, AND METHOD OF PREPARING POLYOLEFIN | LG CHEM, LTD. (KR) | 2017-07-13 | — | — | US | disclosed |
| US-20170198074-A1 | TRANSITION METAL COMPOUND, CATALYST COMPOSITION COMPRISING THE SAME, AND METHOD OF PREPARING POLYOLEFIN | LG CHEM, LTD. (KR) | 2017-07-13 | — | — | US | disclosed |
| US-9644064-B2 | Olefin block copolymer | LG CHEM, LTD. (KR) | 2017-05-09 | — | — | US | disclosed |
| US-9000115-B2 | Olefin block copolymers and production methods thereof | LG CHEM, LTD. (KR) | 2015-04-07 | — | — | US | disclosed |
| US-9000115-B2 | Olefin block copolymers and production methods thereof | LG CHEM, LTD. (KR) | 2015-04-07 | — | — | US | disclosed |
| US-20140114033-A1 | OLEFIN BLOCK COPOLYMERS AND PRODUCTION METHODS THEREOF | LG CHEM, LTD. (KR) | 2014-04-24 | — | — | US | disclosed |
| US-20140066288-A1 | METALLOCENE COMPOUND, CATALYST COMPOSITION COMPRISING THE SAME, AND AN OLEFINIC POLYMER PRODUCED USING THE SAME | LG CHEM, LTD. (KR) | 2014-03-06 | — | — | US | disclosed |
| US-20130296519-A1 | OLEFIN BLOCK COPOLYMER | LG CHEM, LTD. (KR) | 2013-11-07 | — | — | US | disclosed |
| US-20130296497-A1 | OLEFIN BLOCK COPOLYMER | LG CHEM, LTD. (KR) | 2013-11-07 | — | — | US | disclosed |
| US-20130296497-A1 | OLEFIN BLOCK COPOLYMER | LG CHEM, LTD. (KR) | 2013-11-07 | — | — | US | disclosed |
| US-20130296519-A1 | OLEFIN BLOCK COPOLYMER | LG CHEM, LTD. (KR) | 2013-11-07 | — | — | US | disclosed |
| US-20120196985-A1 | OLEFIN BLOCK COPOLYMERS AND PRODUCTION METHODS THEREOF | LG CHEM, LTD. (KR) | 2012-08-02 | — | — | US | disclosed |
| US-20120123078-A1 | METALLOCENE COMPOUND, CATALYST COMPOSITION COMPRISING THE SAME, AND AN OLEFINIC POLYMER PRODUCED USING THE SAME | LG CHEM, LTD. (KR) | 2012-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120123078-A1 | METALLOCENE COMPOUND, CATALYST COMPOSITION COMPRISING THE SAME, AND AN OLEFINIC POLYMER PRODUCED USING THE SAME | NOTUM, OR10J3, COASY | CHRM2 3891/4885HTR1A 3559/4885ADRA2A 4275/4885 |
| US-20170198074-A1 | TRANSITION METAL COMPOUND, CATALYST COMPOSITION COMPRISING THE SAME, AND METHOD OF PREPARING POLYOLEFIN | PARG, TRMT1L, PORCN | CHRM2 4226/4885HTR1A 4741/4885ADRA2A 4876/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.